Adam D. Cutler Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Adam D. Cutler.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Adam D. Cutler. Adam D. Cutler is a Director in NAVIDEA BIOPHARMACEUTICALS, INC. ($NAVB) and a CFO and Treasurer in Molecular Templates, Inc. ($THLD) and a See remarks in Molecular Templates, Inc. ($MTEM) and a Director in InMed Pharmaceuticals Inc. ($INM).
Address: C/O MOLECULAR TEMPLATES, INC. 9301 AMBERGLEN BLVD., SUITE 100 AUSTIN 78729 TX
Companies in which Adam D. Cutler is an Insider
InMed Pharmaceuticals Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Adam D. Cutler: Director
Holdings: 0 shares
Latest Transaction: Dec 18 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Molecular Templates, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Adam D. Cutler: See remarks, CFO and Treasurer
Holdings: 0 shares
Current Value: $0
Latest Transaction: Feb 17 2021
$MTEM Market Capitalization: $41.30M
$MTEM Previous Close: $0.61
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
NAVIDEA BIOPHARMACEUTICALS, INC.
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of Adam D. Cutler: Director
Holdings: 10,000 shares
Current Value: $5,200
Latest Transaction: Jan 14 2021
$NAVB Market Capitalization: $77.59M
$NAVB Previous Close: $0.52
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Adam D. Cutler
Sentiment: All, INM, MTEM, NAVB
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 17 2021 | MTEM | Molecular Template ... | Cutler Adam D. | See remarks | Option Exercise | A | 14.05 | 125,000 | 1,756,250 | 125,000 | |
| Jan 14 2021 | NAVB | NAVIDEA BIOPHARMAC ... | Cutler Adam D. | Director | Option Exercise | A | 2.28 | 2,500 | 5,700 | 2,500 | |
| Jan 14 2021 | NAVB | NAVIDEA BIOPHARMAC ... | Cutler Adam D. | Director | Grant | A | 0.00 | 2,500 | 3 | 10,000 | 7.5 K to 10 K (+33.33 %) |
| Dec 18 2020 | INM | InMed Pharmaceutic ... | Cutler Adam D. | Director | Option Exercise | A | 3.02 | 7,000 | 21,140 | 7,000 | |
| Feb 18 2020 | MTEM | Molecular Template ... | Cutler Adam D. | See remarks | Option Exercise | A | 14.50 | 150,000 | 2,175,000 | 150,000 | |
| Feb 07 2020 | NAVB | NAVIDEA BIOPHARMAC ... | Cutler Adam D. | Director | Option Exercise | A | 1.06 | 2,500 | 2,650 | 7,500 | |
| Feb 07 2020 | NAVB | NAVIDEA BIOPHARMAC ... | Cutler Adam D. | Director | Grant | A | 0.00 | 2,500 | 3 | 7,500 | 5 K to 7.5 K (+50.00 %) |